Bausch Health Companies Inc
BHC7.195USD
+0.015+0.21%
收盘 12/26, 16:00（美东）报价延迟15分钟
2.67B总市值
7.35市盈率 TTM
关于 Bausch Health Companies Inc 公司
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Bausch Health Companies Inc简介
公司代码BHC
公司名称Bausch Health Companies Inc
上市日期Sep 20, 1994
CEOAppio (Thomas J)
员工数量20700
证券类型Ordinary Share
年结日Sep 20
公司地址2150 St. Elzear Blvd. West
城市LAVAL
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Canada
邮编H7L 4A8
电话18003611448
网址https://www.bauschhealth.com/
公司代码BHC
上市日期Sep 20, 1994
CEOAppio (Thomas J)
Bausch Health Companies Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
--
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
199.24K
--
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.66K
+1.00%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
25.38K
+212.92%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
-97.41%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
3.67K
--
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
--
-100.00%
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
--
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
199.24K
--
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.66K
+1.00%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
25.38K
+212.92%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
-97.41%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
3.67K
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
地区USD
名称
营收
占比
United States and Puerto Rico
5.77B
59.92%
Other Foreign Countries
1.08B
11.25%
China (Country)
496.00M
5.15%
Canada
402.00M
4.18%
Poland
350.00M
3.64%
其他
1.53B
15.86%
业务
地区
业务USD
名称
营收
占比
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Paulson & Co. Inc.
19.75%
Meruelo (Alex)
9.91%
GoldenTree Asset Management, LP
9.39%
Nomura Securities Co., Ltd.
4.24%
Healthcare Of Ontario Pension Plan
3.51%
其他
53.20%
持股股东
持股股东
占比
Paulson & Co. Inc.
19.75%
Meruelo (Alex)
9.91%
GoldenTree Asset Management, LP
9.39%
Nomura Securities Co., Ltd.
4.24%
Healthcare Of Ontario Pension Plan
3.51%
其他
53.20%
股东类型
持股股东
占比
Family Office
19.75%
Investment Advisor/Hedge Fund
14.67%
Individual Investor
10.89%
Investment Advisor
9.35%
Research Firm
7.86%
Hedge Fund
5.23%
Bank and Trust
4.46%
Pension Fund
4.11%
Private Equity
1.41%
其他
22.25%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
488
175.10M
70.29%
+43.88K
2025Q3
506
175.09M
71.73%
-42.59M
2025Q2
513
217.71M
72.26%
-4.52M
2025Q1
526
222.33M
72.55%
-45.74M
2024Q4
547
234.63M
78.06%
-1.57M
2024Q3
606
235.66M
83.60%
-25.41M
2024Q2
682
261.12M
90.70%
-4.43M
2024Q1
745
265.27M
94.42%
-80.93M
2023Q4
778
267.72M
94.93%
+4.99M
2023Q3
794
262.66M
89.53%
+17.36M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Paulson & Co. Inc.
70.76M
19.13%
+37.96M
+115.77%
Aug 14, 2025
Meruelo (Alex)
36.76M
9.94%
+148.73K
+0.41%
Mar 31, 2025
GoldenTree Asset Management, LP
34.25M
9.26%
+4.00M
+13.24%
Jun 30, 2025
Nomura Securities Co., Ltd.
21.50M
5.81%
-1.90M
-8.12%
Jun 30, 2025
Healthcare Of Ontario Pension Plan
13.00M
3.52%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
11.70M
3.16%
+23.62K
+0.20%
Jun 30, 2025
National Bank of Canada
7.74M
2.09%
+229.78K
+3.06%
Jun 30, 2025
MFN Partners Management LP
6.00M
1.62%
--
--
Jun 30, 2025
Kohlberg Kravis Roberts & Co. L.P.
5.24M
1.42%
--
--
Jun 30, 2025
RBC Brewin Dolphin
5.20M
1.41%
--
--
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
VanEck Pharmaceutical ETF
0.3%
Gotham 1000 Value ETF
0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
0.12%
Schwab International Small-Cap Equity ETF
0.09%
iShares Intl Small Cap Equity Factor ETF
0.08%
DFA Dimensional International Small Cap ETF
0.07%
Schwab Fundamental International Equity ETF
0.04%
Invesco RAFI Developed Mkts ex-US ETF
0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
iShares Core MSCI International Developed Mkt ETF
0.01%
查看更多
VanEck Pharmaceutical ETF
占比0.3%
Gotham 1000 Value ETF
占比0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
占比0.12%
Schwab International Small-Cap Equity ETF
占比0.09%
iShares Intl Small Cap Equity Factor ETF
占比0.08%
DFA Dimensional International Small Cap ETF
占比0.07%
Schwab Fundamental International Equity ETF
占比0.04%
Invesco RAFI Developed Mkts ex-US ETF
占比0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
占比0.01%
iShares Core MSCI International Developed Mkt ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Bausch Health Companies Inc的前五大股东是谁？
Bausch Health Companies Inc 的前五大股东如下：
Paulson & Co. Inc.持有股份：70.76M，占总股份比例：19.13%。
Meruelo (Alex)持有股份：36.76M，占总股份比例：9.94%。
GoldenTree Asset Management, LP持有股份：34.25M，占总股份比例：9.26%。
Nomura Securities Co., Ltd.持有股份：21.50M，占总股份比例：5.81%。
Healthcare Of Ontario Pension Plan持有股份：13.00M，占总股份比例：3.52%。
Paulson & Co. Inc.持有股份：70.76M，占总股份比例：19.13%。
Meruelo (Alex)持有股份：36.76M，占总股份比例：9.94%。
GoldenTree Asset Management, LP持有股份：34.25M，占总股份比例：9.26%。
Nomura Securities Co., Ltd.持有股份：21.50M，占总股份比例：5.81%。
Healthcare Of Ontario Pension Plan持有股份：13.00M，占总股份比例：3.52%。
Bausch Health Companies Inc的前三大股东类型是什么？
Bausch Health Companies Inc 的前三大股东类型分别是：
Paulson & Co. Inc.
Meruelo (Alex)
GoldenTree Asset Management, LP
Paulson & Co. Inc.
Meruelo (Alex)
GoldenTree Asset Management, LP
有多少机构持有Bausch Health Companies Inc(BHC)的股份？
截至2025Q4，共有488家机构持有Bausch Health Companies Inc的股份，合计持有的股份价值约为175.10M，占公司总股份的70.29%。与2025Q3相比，机构持股有所增加，增幅为-1.44%。
哪个业务部门对Bausch Health Companies Inc的收入贡献最大？
在FY2024，Pharmaceutical Products业务部门对Bausch Health Companies Inc的收入贡献最大，创收4.40B，占总收入的45.67%。
